CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Open-market sale Principal Accounting Officer sold 1,559 shares at an average $405.57 ($632,277)
- 4 Planned sale SVP, General Counsel sold 1,115 shares at an average $400.82 ($446,910)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Director sold 31,028 shares at an average $362.97 ($11,262,131)
- 4 Planned sale Director sold 31,027 shares at an average $350.99 ($10,890,074)
- 4 Planned sale SVP, General Counsel sold 1,115 shares at $375.00 ($418,125)
- 4 Planned sale Director sold 31,028 shares at an average $364.79 ($11,318,558)
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Option exercise Director acquired 61,536 shares (option exercise)
- 4 Planned sale Director sold 38,287 shares at an average $349.10 ($13,366,092)
- 144 Insider Sale of Securities
- 4 Open-market sale Principal Accounting Officer sold 132 shares at $355.86 ($46,974)
- 144 Insider Sale of Securities
- 4 Planned sale President and COO sold 280 shares at $380.00 ($106,400)
- 8-K Event Results of operations
- 144 Insider Sale of Securities
Page 1 of 64 · 1,277 filings